Expanded access program of cretostimogene grenadenorepvec in patients with non-muscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin.

Authors

Sarah P. Psutka, University of Washington, Seattle
Sima P. Porten, University of California, San Francisco
Kristen R. Scarpato, Vanderbilt University
Mary E. Westerman, LSU Health Sciences Center - New OrleansFollow
Suzanne B Merrill, Milton S. Hershey Medical Center, PA
Anne K. Schuckman, University of Southern California, Los Angeles

Document Type

Conference Proceeding

Publication Date

2-20-2025

Publication Title

Journal of Clinical Oncology

Abstract

2025 ASCO Genitourinary Cancers Symposium; January 23 - 25, 2025; San Francisco, CA

First Page

TPS902

Volume

43

Publisher

American Society of Clinical Oncology

Comments

Abstract TPS902

Recommended Citation

Psutka, Sarah P.; Porten, Sima P.; Scarpato, Kristen R.; Westerman, Mary E.; Merrill, Suzanne B; and Schuckman, Anne K., "Expanded access program of cretostimogene grenadenorepvec in patients with non-muscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin." (2025). School of Medicine Faculty Publications. 3615.
https://digitalscholar.lsuhsc.edu/som_facpubs/3615
10.1200/JCO.2025.43.5_suppl.TPS902